Posted inHealth
Moderna’s Strategic Shift Toward Oncology Therapeutics Drives Significant Market Growth
Biotechnology firm Moderna experienced a dramatic market resurgence over the past year, with its stock surging by 177 percent following a strategic pivot toward oncology development. Driven by declining revenues…
